Abstract
Lay Summary We review concerns regarding use of placebo in clinical trials of inflammatory bowel disease. We propose alternate designs to overcome ethical issues, while providing data that are clinically relevant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have